Kevin Patrick Danahy - 16 Nov 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Chief Executive Officer
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
16 Nov 2023
Net transactions value
+$35,156
Form type
4
Filing time
17 Nov 2023, 09:11:44 UTC
Previous filing
03 Nov 2023
Next filing
09 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $31,172 +4,781 +16% $6.52 35,275 16 Nov 2023 Direct
transaction PLSE Common Stock Purchase $3,906 +600 +1.7% $6.51 35,875 16 Nov 2023 Direct
transaction PLSE Common Stock Purchase $78 +12 +0.03% $6.50 35,887 16 Nov 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.